Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The primary aim of the study is to compare the efficacy of single-administration low-dose
glucagon and split-administration low-dose glucagon to placebo for prevention of
exercise-induced hypoglycemia in people with type 1 diabetes using insulin pumps and multiple
daily injections (MDI).
The secondary aim is to compare the accuracy of three continuous glucose monitors (CGM)
during and after exercise in inpatient and outpatient settings.